CD59转染细胞Caspase?3和Bcl?2基因的表达(3)

【参考文献】
  [1]DONIN, JURIANZ K, ZIPOREN L, et al. Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid[J]. Clin Exp Immunol, 2003,131(2):254?263. 

　　[2]FISHELSON Z, DONIN N, ZELL S, et al. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors[J]. Mol Immunol, 2003,40(2?4):109?123. 

　　[3]FONSATTI E, DI GIACOMO A M, MAIO M. Optimizing complement?activating antibody?based cancer immunotherapy: a feasible strategy[J]? J Transl Med, 2004,2(1):21?25.

　　[4]RAVINDRANATH N M, NISHIMOTO K, CHU K, et al. Cell?surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo?immunotherapy[J]. Anticancer Res, 2000,20(1A):21?26.

　　[5]朱新红,高美华,任书荣,等. CD59 基因的突变并真核表达载体的构建[J]. 青岛大学医学院学报, 2008,44(2):95?98.

　　[6]FROMOROMOWITZ F B, VIOLA M V, CHAO S, et al. Ras p21 expression in the progression of breast cancer[J]. Hum Pathol, 1987,18(12):1268?1275.

　　[7]HUGHES J, NANGAKU M, ALPERS C E, et al. C5b?9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis[J]. Am J Physiol Renal Physiol, 2000, 278(5):F747?757.

　　[8]KAWANO M, TSUNODA S, KONI I, et al. Decreased expression of 20 kD homologous restriction factor (HRF20, CD59) on Tlymphocytes in Epstein?Barr virus (EBV)?induced infectious mononucleosis[J]. Clin Exp Immunol, 1997,108(2):260?265.

　　[9]JONES J, MORGAN B P. Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation[J]. Immunology, 1995,86(4):651?660.

百度搜索“77cn”或“免费范文网”即可找到本站免费阅读全部范文。收藏本站方便下次阅读，免费范文网，提供经典小说医药类CD59转染细胞Caspase?3和Bcl?2基因的表达(3)在线全文阅读。